The Footnote

A World on Its Toes: The Unspoken Pandemic of Diabetes, Ulcer & Amputation

Author attribution not recorded

A metronome where the pendulum is a footprint, symbolizing the ticking time bomb of preventable diabetic foot amputations.

A Footnote call to Action

The ticking metronome of lost limbs

Every 20 seconds a surgeon somewhere in the world removes part of a leg from a person with diabetes – that’s three limbs by the time you reach the end of this paragraph.(1)  The global conversation still fixates on blood glucose targets and blockbuster drugs, yet the literal, flesh-and-bone consequences accumulate quietly at floor-level. Diabetes is no longer a chronic disease; it is an era-defining humanitarian emergency that now engulfs 590 million adults, or one in nine on the planet.(2) By 2050, we are on course for 853 million cases – a 46 % jump that risks overwhelming every health system, rich or poor.(2)

The disaster is not evenly shared. A 2024 Lancet analysis warned that the headline figure may already top 800 million when undiagnosed and undocumented regions are factored in, with the steepest climbs in low- and middle-income countries.(3) Yet political urgency lags decades behind epidemiology. The result: an epidemic of preventable ulcers, catastrophic amputations and death rates that would be intolerable in oncology or cardiology.

This article sets out the scale of the carnage, the economics that make it everyone’s problem, and a Footnote manifesto that dares policymakers to stop dithering.

 

Diabetes: bigger than COVID, quieter than a whisper

Prevalence – IDF’s 11th Atlas places adult diabetes prevalence at 11.1 %,(2) but modelling by international collaborators now hints at far higher real-world numbers.(3)

Under-diagnosis – 40 % of cases (≈252 million people) have no formal diagnosis, walking blindfolded toward complications.(2)

Deaths – Diabetes and its sequelae killed 6.7 million adults in 2021 – one every five seconds.(4)

Money – Annual global health expenditure hit US $ 966 billion in 2021 and is forecast to burst through US $ 1 trillion by 2024.(5)

 

Foot ulcers: the slow-burning fuse

Diabetic foot ulcer (DFU) is the gateway complication, forming where neuropathy, ischaemia and neglect intersect. A landmark meta-analysis spanning 33 countries and 800 000 participants calculated a 6.3 % point prevalence of active DFU among people with diabetes.(6) Translated to today’s caseload, that equals ~37 million weeping wounds. Lifetime risk is conservatively pegged at 15 %.(7)

DFUs are not benign potholes; they are the leading precipitant of non-traumatic limb loss. More than 80 % of amputations in diabetes are preceded by an ulcer that failed to heal (or failed to be noticed).(8)

 

Amputation: anatomy of an avoidable catastrophe

Incidence – Over one million diabetes-related lower-extremity amputations (LEAs) occur every year – a limb every 20 seconds.(1)

Risk multiplier – Having diabetes multiplies the chance of amputation between seven- and forty-fold versus non-diabetic peers.(9)

Global variability – Incidence ranges from <3 to >30 per 100 000 in high-income nations and is often unrecorded in low-income countries.(10)

Mortality – Five-year mortality after a major LEA now exceeds 70 %, eclipsing many common cancers.(11)

The sad irony is that 85 % of these amputations could be prevented with timely detection, vascular optimisation and multidisciplinary care. (12) Yet workforce shortages, reimbursement gaps and siloed practice keep evidence-based foot teams a luxury, not a norm.

 

The haemorrhage of money

Complications below the ankle are a fiscal black hole:

Direct costs – In Australia alone, diabetic foot disease drains AU $ 875 million per year. (12)

Per-patient hit – A single major amputation costs ~US $ 23 500 up-front and >US $ 50 000 over five years, without factoring social care and lost productivity. (12)

Market signal – The DFU treatment market was already worth US $ 5.2 billion in 2023 and will almost double within a decade, a perverse index of collective failure. (13)

Investors cheer, treasuries bleed.

 

Inequity: the brutal geography of limb loss

Amputation is not distributed by HbA1c alone.

Low- and middle-income countries house 81 % of the global diabetes population yet have the thinnest safety nets.(2)

Indigenous Australia – Aboriginal and Torres Strait Islander Australians with diabetes are 38 times more likely to undergo a major LEA than non-Indigenous peers.(12)

Ethnic minorities elsewhere show amputation rates 1.5- to 3-fold higher than majority populations even after adjusting for access.(10)

This is structural violence in slow motion.

 

Why are we still chopping legs? – the action gap

The science is not controversial. Multidisciplinary foot clinics, vascular-led revascularisation, off-loading technology and aggressive infection control all slash amputation risk. Meta-analyses report 24-90 % reductions where such models are fully funded. (12)

What sabotages delivery?

  1. Policy inertia – Many national diabetes plans ignore foot disease entirely.

  2. Payment perverse incentives – Hospitals are reimbursed for “rescue surgery” but not for podiatry-led prevention.

  3. Workforce neglect – Chronic under-supply of podiatrists, vascular surgeons and wound nurses, especially outside capitals.

  4. Data darkness – Vast territories still have no registry tracking ulcers or amputations, so tragedies remain invisible.

 

The Footnote Manifesto – ten steps that could stop the bleeding

  1. Screen every sole – annual foot risk assessment for all people with diabetes, integrated into primary-care quality frameworks.

  2. Fund podiatry as core, not cosmetic – reimbursements that cover debridement, off-loading and orthoses before infection sets in.

  3. 24-hour hot-foot lines – triage pathways that fast-track new ulcers to vascular-podiatry units within 48 h.

  4. Universal shoe subsidy – evidence-based footwear for high-risk feet, templated on the WHO Assistive Devices List.

  5. National registries – real-time dashboards of DFU incidence, healing times and amputation outcomes to shame laggards and celebrate leaders.

  6. Indigenous-led programs – co-designed foot-care services addressing cultural safety and remote logistics.

  7. Mandate multidisciplinary clinics – every hospital managing diabetes complications must offer an accredited foot team.

  8. Tax sugar to fund limbs – hypothecate revenues from sugary-drink taxes to prevention clinics and prosthetics.

  9. Innovate wisely – channel R&D toward prevention tech (smart insoles, thermal imaging) instead of just pricier dressings.

  10. Narrative shift – stop depicting limb loss as an inevitable “complication” and label it what it is: a systems failure.

 

Time to stand up

History will record that we could measure diabetes to the molecule, yet still allowed millions to bleed and die from ankle-level neglect. We cannot inject our way out of this crisis. We must walk out of it – on feet that remain attached. The scalpel is not destiny; policy is. The next limb saved might be ours.

 

References

  1. Liu R, Petersen BJ, Rothenberg GM, Armstrong DG. Lower extremity reamputation in people with diabetes: a systematic review and meta-analysis. BMJ Open Diabetes Res Care. 2021;9:e002325. BMJ Decision Resources

  2. International Diabetes Federation. IDF Diabetes Atlas, 11th ed. Brussels: IDF; 2025. International Diabetes Federation

  3. Topping A. More than 800 million people worldwide have diabetes, study finds. The Guardian. 13 Nov 2024. The Guardian

  4. International Diabetes Federation. Diabetes around the world in 2021: global fact sheet. Brussels: IDF; 2021. publichealthupdate.com

  5. International Diabetes Federation. Global diabetes-related health expenditure factsheet. Brussels: IDF; 2024. Diabetes Atlas [source link unavailable; citation retained]International Diabetes Federation

  6. Zhang P, Lu J, Jing Y, et al. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Ann Med. 2017;49(2):106-116. Europe PMC

  7. Tan T, Shaw EJ, Siddiqui F, et al. Inpatient management of diabetic foot problems: summary of NICE guidance. BMJ. 2011;342:d1280. BMJ

  8. Hicks CW, Selvarajah S, Mathioudakis N, et al. Diabetic foot ulcers and their recurrence. Diabetes Care. 2023;46(1):209-221. BMJ Decision Resources

  9. Morbach S, Furchert H, Gröblinghoff U, et al. Lower-extremity amputation and mortality in diabetes. Diabetes Care. 2012;35(10):2021-2027. Diabetes Journals

  10. Bellia A, Meloni M, Andreadi A, et al. Geographic and ethnic inequalities in diabetes-related amputations. Front Clin Diabetes Healthc. 2022;3:855168. Frontiers

  11. Vladu M, Bala CG, Pricop C, et al. Lower extremity amputations in diabetes: five-year mortality exceeds 70 %. Medicina. 2024;60(12):2001. MDPI

  12. Diabetes Australia. Amputations evidence: facts and figures. Canberra: Diabetes Australia; 2023. Diabetes Australia [source link unavailable; citation retained]

  13. Grand View Research. Diabetic Foot Ulcer Treatment Market Size Report 2023–2030. San Francisco: Grand View Research; 2024. Grand View Research

Simplified complete reading view